| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006030208A1 Amino acid |
| 03/23/2006 | WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols |
| 03/23/2006 | WO2006029532A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | WO2005052016A3 Bottom antireflective coatings |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 03/23/2006 | US20060063932 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 03/23/2006 | US20060063864 Diindole substituted squarylium compound; filters capable of selectively blocking light with wavelengths that degrade color purity |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | DE102004044827A1 Jod-phenylsubstituierte cyclische Ketoenole Iodine-substituted cyclic ketoenols |
| 03/23/2006 | CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols |
| 03/23/2006 | CA2580131A1 Substituted aniline derivatives |
| 03/23/2006 | CA2579799A1 Benzoyl-substituted serine amides |
| 03/22/2006 | EP1637141A1 Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease |
| 03/22/2006 | EP1636182A2 Prodrugs of mitotic kinesin inhibitors |
| 03/22/2006 | EP1636180A1 Process for rectifying n-vinyl-2-pyrrolidone |
| 03/22/2006 | EP1635816A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP0933379B1 Novel peptide derivatives having thiazolyl-alanine residue |
| 03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
| 03/22/2006 | CN1751022A Method for production of the R,R (or S,S) configuration of glycopyrronium stereoisomers |
| 03/22/2006 | CN1749248A Process for preparing high purity atorvastatin calcium |
| 03/22/2006 | CN1749247A Process for preparing high purity crystal atorvastatin sodium |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246310C Synthesis method of cinepazide maleate |
| 03/21/2006 | US7015320 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7014697 Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 03/21/2006 | CA2521933C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2263983C Cyclic amine derivatives for inhibiting blood platelet aggregation |
| 03/21/2006 | CA2043955C Pesticidal 1-arylpyrroles |
| 03/16/2006 | WO2006028525A2 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/16/2006 | WO2006028500A1 Sulpiride derivatives pharmaceutical compositions |
| 03/16/2006 | WO2006027252A1 Sigma receptor ligands |
| 03/16/2006 | WO2006027186A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors |
| 03/16/2006 | WO2006027135A1 4-aminomethyl benzamidine derivatives and their use as factor viiia inhibitors |
| 03/16/2006 | WO2005115361A3 Androgen receptor modulators and method of treating disease using the same |
| 03/16/2006 | WO2005113503A3 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058534 Method for purifying N-(2-hydroxyethyl)-2-pyrrolidone |
| 03/16/2006 | US20060058533 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/16/2006 | US20060058513 Oxime conjugates and methods for their formation and use |
| 03/16/2006 | US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors |
| 03/16/2006 | DE102004038109A1 Stabilisatoren für die NVP-Synthese Stabilizers for the NVP synthesis |
| 03/16/2006 | CA2578231A1 Sulpiride derivatives pharmaceutical compositions |
| 03/16/2006 | CA2577610A1 Sigma receptor ligands |
| 03/16/2006 | CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
| 03/16/2006 | CA2565235A1 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/15/2006 | EP1634883A1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d]pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 03/15/2006 | EP1634877A1 Mixture and compounds from mycelia of antrodia camphorata and use thereof |
| 03/15/2006 | EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633708A1 Process for the preparation of n-alkyl-pyrrolidones |
| 03/15/2006 | EP1633707A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 03/15/2006 | EP1633703A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 03/15/2006 | EP1633702A1 Protease inhibitors |
| 03/15/2006 | EP1633343A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers |
| 03/15/2006 | EP1633310A2 Thiotungstate analogues and uses thereof |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1242373B1 A process for producing crystalline atorvastatin calcium |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1747930A Compounds having prolyl oligopeptidase inhibitory activity |
| 03/15/2006 | CN1747929A Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 03/15/2006 | CN1245384C Carboxamides as fungicides in agriculture |
| 03/15/2006 | CN1245383C Process for preparing zofenopril |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245380C Anthranilic acid derivatives |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | CA2521953C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 03/14/2006 | CA2294342C Process for synthesizing carbapenem side chain intermediates |
| 03/14/2006 | CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 03/09/2006 | WO2006024777A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 03/09/2006 | WO2006024722A1 Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports |
| 03/09/2006 | WO2006024501A1 Alternative synthesis of renin inhibitors and intermediates thereof |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 03/09/2006 | US20060052615 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052588 Novel nitrosation polymer in organic synthesis |
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052337 Polysaccharide and composition from Antrodia camphorata and use thereof |
| 03/09/2006 | US20060052314 Pharmaceutical combination |
| 03/09/2006 | US20060052311 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP) |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | US20060049061 electrooxidation reaction using 2-(N-pyrrolidine)-N,N,N-triethylethanammonium tetrafluoroborate or 3-N-piperidine-N,N,N-triethylammoniopropanesulphonamide tetrafluoroborate; proline final product |
| 03/09/2006 | CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 03/09/2006 | CA2576717A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |